Abstract
Purpose
To determine the impact of visual impairment (VI) on health-related quality of life (HRQoL) and to compare the health burden of VI in different areas in mainland China.
Methods
A cohort of 6830 people from rural villages and a cohort of 3251 people from an urban city were included to receive comprehensive ophthalmologic examinations and complete the European Quality of Life-5 Dimensions 3 Levels (EQ-5D-3L) questionnaire. For urban and rural populations, a unified VI grouping standard was adopted: the eyes were classified into normal group, mild–moderate group, and severe group according to WHO standards, and then divided into 6 groups considering both eyes. We estimated the effects of VI on the EQ-5D index score using linear regression models and the association between VI and self-reported EQ-5D health problems using logistic regression models. Associations were assessed by the Spearman correlation coefficient.
Results
The prevalence of VI and the index scores of EQ-5D-3L for each subgroup of VI were higher for the rural cohort. In these two cohorts, the severity of VI in rural population (Spearman r = 0.205; p < 0.0001) and urban population (Spearman r = 0.164; p < 0.0001) is correlated with the EQ-5D index score. In the rural cohort, the difference in index scores with bilateral severe VI compared to those without VI, after adjusting for covariates, was − 0.053 for the rural cohort and − 0.084 for the urban cohort, respectively. In the rural cohort, the odds ratio for bilateral severe VI was 4.39 for mobility, 6.33 for self-care, and 5.88 for usual activities. The incidence of anxiety or depression and pain or discomfort in the urban cohort was greater; the OR for bilateral severe VI in the urban cohort was 4.75.
Conclusions
VI has a negative impact on HRQoL in the rural and urban areas of China, especially in urban population. It is also more likely to cause anxiety or depression among the urban cohort, which deserves special attention.
Similar content being viewed by others
Data availability
The data of the current study are available from the corresponding author on reasonable request.
Abbreviations
- QoL:
-
Quality of life
- EQ-5D-3L:
-
European Quality of Life-5 Dimensions 3 Levels questionnaire
- VI:
-
Visual impairment
- HRQoL:
-
Health-related quality of life
- VRQoL:
-
Vision-related quality of life
- HES:
-
The Handan Eye Study
- BES:
-
The Beijing Eye Study
- VA:
-
Visual acuity
References
Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor H, Bourne RRA (2013) Global prevalence of vision impairment and blindness: magnitude and temporal trends. Ophthalmology 120:2377–2384
Flaxman SR, Bourne RR, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GAA, Tahhan N, Wong TY, Taylor HR (2017) Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health 5:e1221–e1234
Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE (2005) Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 123:807–814
Hassell JB, Lamoureux EL, Keeffe JE (2006) Impact of age related macular degeneration on quality of life. Br J Ophthalmol 90:593–596
Varma R, Wu J, Chong K, Azen SP, Hays RD, Los Angeles Latino Eye Study Group (2006) Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113:1846–1853
Zhou C, Qian S, Wu P, Qiu C (2014) Quality of life of glaucoma patients in China: sociodemographic, clinical, and psychological correlates—a cross-sectional study. Qual Life Res 23:999–908
He M, Xu J, Li S, Wu K, Munoz SR, Ellwein LB (1999) Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology 106:1609–1615
Kymes SM (2008) The role of preferencebased measures of health states: how can we use the vision preference value scale. Arch Ophthalmol 126:1765–1766
Frick KD, Massof RW (2009) Use of global visual acuity data in a time trade-off approach to calculate the cost utility of cataract surgery: methodological issues of cost-utility comparisons. Arch Ophthalmol 127:1205–1206
Rabin R, Charro FD (2011) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337–343
Brooks R, Group E (1996) EuroQol: the current state of play. Health Policy 37:53–72
LinJ C, Yu JH (2012) Assessment of quality of life among Taiwanese patients with visual impairment. J Formos Med Assoc 111:572–579
Polack S, Kuper H, Wadud Z, Fletcher A, Foster A (2008) Quality of life and visual impairment from cataract in Satkhira district, Bangladesh. Br J Ophthalmol 92:1026–1030
Van Nispen RM, de Boer MR, Hoeijmakers JG, Ringens PJ, van Rens GH (2009) Co-morbidity and visual acuity are risk factors for health-related quality of life decline: five-month follow-up EQ-5D data of visually impaired older patients. Health Qual Life Outcomes 7:18
Lee JE, Fos PJ, Zuniga MA, Kastl PR, Sung JH (2003) Health-related quality of life of cataract patients: cross-cultural comparisons of utility and psychometric measures. Ophthalmic Epidemiol 10:177–191
Pagano IS, Gotay CC (2005) Ethnic differential item functioning in the assessment of quality of life in cancer patients. Health Qual Life Outcomes 3:60
Xu L, Li J, Cui T, Hu A, Fan G, Zhang R (2005) Refractive error in urban and rural adult Chinese in Beijing. Ophthalmology 112:1676–1683
Xu L, Li J, Cui T, Hu A, Zheng Y, Li Y, Sun B, Ma B, Jonas JB (2005) Visual acuity in northern China in an urban and rural population: the Beijing Eye Study. Br J Ophthalmol 89:1089–1093
Liang YB, Friedman DS, Wong TY, Wang FH, Duan XR, Yang XH, Zhou Q, Tao Q, Zhan SY, Sun LP, Wang NL, Handan Eye Study Group (2009) Rationale, design, methodology, and baseline data of a population-based study in rural China: the Handan Eye Study. Ophthalmic Epidemiol 16:115–127
Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35:1095–1008
Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J (2003) Validity and reliability of the EQ-5D self-report questionnaire in English- speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 12:87–92
Ang M, Fenwick E, Wong TY, Lamoureux E, Luo N (2013) Utility of EQ-5D to assess patients undergoing cataract surgery. Optom Vis Sc 90:861–866
Broman AT, Munoz B, Rodriguez J, Sanchez R, Quigley HA, Klein R, Snyder R, West SK (2002) The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci 43:3393–3398
Macedo AF, Ramos PL, Hernandez ML, Cima J, Baptista A, Marques AP, Massof R, Santana R (2017) Visual and health outcomes, measured with the activity inventory and the EQ-5D, in visual impairment. Acta Ophthalmol 95:e783–e791
Xingzhi Wang, Ecosse Lamoureux, Yingfeng Zheng, Marcus Ang, FAMS, FRCSEd, Tien Yin Wong, Nan Luo (2014) Health burden associated with visual impairment in Singapore. Ophthalmology 121:1837–1842
Guan X, Fu M, Lin F, Zhu D, Vuillermin D, Shi L (2019) Burden of visual impairment associated with eye diseases: exploratory survey of 298 Chinese patients. BMJ Open 9:e030561
Varma R, Wu J, Chong K, Azen SP, Hays RD (2006) Los Angeles Latino Eye Study Group. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113:1846–1853
Bourne R, Price H, Stevens G, GBD Vision Loss Expert Group (2012) Global burden of visual impairment and blindness. Arch Ophthalmol 130:645–657
Wang JJ, Mitchell P, Smith W, Cumming RG, Attebo K (1999) Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 40:12–19
Wang JJ, Mitchell P, Cumming RG, Smith W (2003) Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study. Ophthalmic Epidemiol 10:3–13
Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, Ramakrishnan R, Robin AL (2005) Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 46:2308–2312
Ong SY, Cheung CY, Li X, Lamoureux EL, Ikram MK, Ding J, Cheng CY, Haaland BA, Saw SM (2012) Visual impairment, age-related eye diseases, and cognitive function: the Singapore Malay Eye Study. Arch Ophthalmol 130:895–900
Polack S, Kuper H, Wadud Z, Fletcher A, Foster A (2008) Quality of life and visual impairment from cataract in Satkhira district. Bangladesh Br J Ophthalmol 92:1026–1030
Varma R, Wu J, Chong K, Azen SP, Hays RD, Los Angeles Latino Eye Study Group (2006) Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113:1846–1853
Hang My Tran, Abdull M Mahdi, Selvaraj Sivasubramaniam, Murthy V S Gudlavalleti, Clare E Gilbert, Shaheen P Shah, C C Ezelum, Tafifida Abubakar, Olufunmilayo O Bankole, on behalf of the Nigeria National Blindness and Visual Impairment Study Group. Quality of life and visual function in Nigeria: findings from the National Survey of Blindness and Visual Impairment
Langelaan M, de Boer MR, van Nispen RM, Wouters B, Moll AC, van Rens GH (2007) Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol 14:119–126
Wu AW, Jacobson DL, Berzon RA, Revicki DA, van der Horst C, Fichtenbaum CJ, Saag MS, Lynn L, Hardy D, Feinberg J (1997) The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res 6:3–10
Acknowledgements
The authors wish to thank the Beijing Tongren Hospital and all local hospitals in Hebei Yongnian county that are involved in this study for their assistance. All survey participants are greatly appreciated for their valuable contributions.
Funding
This work was supported by the “Yangfan Plan” and clinical innovation projects of the Beijing Municipal Administration of Hospitals, funded by the Chinese government (No. ZYLX2015). The funding body should be WNL; he took responsibility of the research, and also contributed to design, acquisition of funding, interpretation of data, general supervision of the research group, and revision of the manuscript for important intellectual content.
Author information
Authors and Affiliations
Consortia
Contributions
WJ conceived of the study, collected the data, and drafted the manuscript. WJ and CK performed the statistical analysis and interpretation of data. LCX and DYF collected the data and did a critical revision of the manuscript. LJY conducted a critical revision of the manuscript. JQQ revised the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Ethical approval and consent to participate.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study obtained the ethical clearance from the Beijing Tongren Hospital Ethical Committee, according to the Helsinki Declaration. Written informed consent was obtained from all participants. For those who were illiterate or blind, we read the consent form to them and asked them to mark the consent form with an inked forefinger, and the consent form with an inked forefinger that was obtained from illiterate participants was also approved by the Ethics committee.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, J., Ji, Q.Q., Lin, C.X. et al. Burden of visual impairment in mainland China: the Handan Eye Study and Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol 259, 3501–3509 (2021). https://doi.org/10.1007/s00417-021-05234-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05234-9